MBX – mbx biosciences, inc. (US:NASDAQ)
Stock Stats
News
MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
MBX Biosciences to Participate in Upcoming November Investor Conferences
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $44.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.
Form SC 13G MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 10-Q MBX Biosciences, Inc. For: Sep 30
Form 8-K MBX Biosciences, Inc. For: Nov 07
Form SC 13G MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
Form SC 13D MBX Biosciences, Inc. Filed by: Norwest Venture Partners XVI, LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.